JP2010527939A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010527939A5 JP2010527939A5 JP2010508671A JP2010508671A JP2010527939A5 JP 2010527939 A5 JP2010527939 A5 JP 2010527939A5 JP 2010508671 A JP2010508671 A JP 2010508671A JP 2010508671 A JP2010508671 A JP 2010508671A JP 2010527939 A5 JP2010527939 A5 JP 2010527939A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- binding fragment
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93140207P | 2007-05-23 | 2007-05-23 | |
| AU2007902751A AU2007902751A0 (en) | 2007-05-23 | Neutralizing antibodies | |
| PCT/AU2008/000728 WO2008141391A1 (en) | 2007-05-23 | 2008-05-23 | Neutralizing antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010527939A JP2010527939A (ja) | 2010-08-19 |
| JP2010527939A5 true JP2010527939A5 (enExample) | 2011-07-07 |
Family
ID=40031329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010508671A Pending JP2010527939A (ja) | 2007-05-23 | 2008-05-23 | 中和抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110044996A1 (enExample) |
| EP (1) | EP2160407A4 (enExample) |
| JP (1) | JP2010527939A (enExample) |
| CN (1) | CN101687926A (enExample) |
| AU (1) | AU2008253608A1 (enExample) |
| CA (1) | CA2687791A1 (enExample) |
| WO (1) | WO2008141391A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8398972B2 (en) | 2006-11-21 | 2013-03-19 | Kalobios Pharmaceuticals, Inc. | Methods of treating dementia using a GM-CSF antagonist |
| WO2009062238A1 (en) * | 2007-11-12 | 2009-05-22 | Crc For Asthma And Airways Ltd | Epitope for neutralizing antibodies |
| CA2747206C (en) | 2008-12-22 | 2018-04-24 | The University Of Melbourne | Pain treatment |
| CN102271705A (zh) * | 2008-12-22 | 2011-12-07 | 墨尔本大学 | 骨关节炎治疗 |
| WO2011153592A1 (en) * | 2010-06-10 | 2011-12-15 | Crc For Asthma And Airways Ltd | Therapeutic molecules |
| US9567397B2 (en) * | 2010-11-18 | 2017-02-14 | Merck Serono S.A. | Antibody with specificity for GM-CSF (I) |
| US9567398B2 (en) * | 2010-11-18 | 2017-02-14 | Merck Serono S.A. | Antibody with specificity for GM-CSF (II) |
| CN103827143A (zh) | 2011-07-06 | 2014-05-28 | 莫弗系统股份公司 | 抗cd20抗体和抗gm-csf抗体的治疗性组合产品及其用途 |
| GB201220242D0 (en) * | 2012-11-09 | 2012-12-26 | Fusion Antibodies Ltd | Antibody |
| JP6490419B2 (ja) * | 2014-12-24 | 2019-03-27 | 学校法人関西医科大学 | 制御性ｔ細胞分化誘導剤 |
| WO2016148653A1 (en) * | 2015-03-17 | 2016-09-22 | Agency For Science, Technology And Research | A serotype cross-reactive, dengue neutralizing antibody and uses thereof |
| CN107840885B (zh) * | 2016-09-19 | 2020-11-10 | 天境生物科技(上海)有限公司 | Gm-csf抗体及其用途 |
| SG11201901789WA (en) * | 2016-09-19 | 2019-03-28 | I Mab | Anti-gm-csf antibodies and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2060741A1 (en) * | 1991-02-11 | 1992-08-12 | Robert S. Greenfield | Gm-csf inhibiting oligopeptides |
| US5874082A (en) * | 1992-07-09 | 1999-02-23 | Chiron Corporation | Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation |
| US20040242847A1 (en) * | 2000-10-20 | 2004-12-02 | Naoshi Fukushima | Degraded agonist antibody |
| JP2006500905A (ja) * | 2002-02-13 | 2006-01-12 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ヒト化ｇｍ−ｃｓｆ抗体 |
| BRPI0608281B8 (pt) * | 2005-04-18 | 2021-05-25 | Amgen Res Munich Gmbh | anticorpo monoclonal humano ou seu fragmento, seu uso no tratamento de doenças inflamatórias, bem como composição farmacêutica que o compreende |
| RU2447085C2 (ru) * | 2005-05-18 | 2012-04-10 | МорфоСис АГ | Анти-gm-csf антитела и их применение |
| JP4736037B2 (ja) * | 2005-10-26 | 2011-07-27 | 株式会社イーベック | ヒトｇｍ−ｃｓｆに結合するヒトのモノクローナル抗体並びにその抗原結合部分 |
| TW200918553A (en) * | 2007-09-18 | 2009-05-01 | Amgen Inc | Human GM-CSF antigen binding proteins |
| WO2009062238A1 (en) * | 2007-11-12 | 2009-05-22 | Crc For Asthma And Airways Ltd | Epitope for neutralizing antibodies |
| CN104072613A (zh) * | 2007-11-13 | 2014-10-01 | Evec股份有限公司 | 与hGM-CSF结合的单克隆抗体及包含它的药物组合物 |
-
2008
- 2008-05-23 CN CN200880023397A patent/CN101687926A/zh active Pending
- 2008-05-23 CA CA002687791A patent/CA2687791A1/en not_active Abandoned
- 2008-05-23 AU AU2008253608A patent/AU2008253608A1/en not_active Abandoned
- 2008-05-23 JP JP2010508671A patent/JP2010527939A/ja active Pending
- 2008-05-23 EP EP08747994A patent/EP2160407A4/en not_active Withdrawn
- 2008-05-23 US US12/601,514 patent/US20110044996A1/en not_active Abandoned
- 2008-05-23 WO PCT/AU2008/000728 patent/WO2008141391A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010527939A5 (enExample) | ||
| JP2021526022A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2014511179A5 (enExample) | ||
| JP2021531254A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| JP2012504955A5 (enExample) | ||
| JP2010536384A5 (enExample) | ||
| JP2009517057A5 (enExample) | ||
| CN110582511A (zh) | 抗N3pGlu淀粉状蛋白β肽抗体及其用途 | |
| JP2013198490A5 (enExample) | ||
| RU2009120052A (ru) | Композиции и способы связывания сфингозин-1-фосфата | |
| JP2014512809A5 (enExample) | ||
| JP2016516400A5 (enExample) | ||
| JP2011207882A5 (enExample) | ||
| RU2010120879A (ru) | Антитела против g-белка распираторно-синцитиального вируса (rsv) | |
| JP2011514150A5 (enExample) | ||
| RU2018100820A (ru) | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА И АНТИТЕЛА С СОЗРЕВШЕЙ АФФИННОСТЬЮ ПРОТИВ FcRH5 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2015525795A5 (enExample) | ||
| RU2013143358A (ru) | Анти-fgfr4 антитела и способы их применения | |
| JP2013542194A5 (enExample) | ||
| JP2017507652A5 (enExample) | ||
| KR20230155605A (ko) | 이중 특이적 항체 | |
| JP2011526785A5 (enExample) | ||
| JP2017514461A5 (enExample) |